Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis

PURPOSE: In immune-mediated rheumatic diseases (IMRDs), persistence to treatment may be used as a surrogate marker for long-term treatment success. In previous comparisons of persistence to tumor necrosis factor α inhibitors (TNFis), a paucity of data for subcutaneous (SC) golimumab was identified....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Patient Prefer Adherence
Asıl Yazarlar: Svedbom, Axel, Storck, Chiara, Kachroo, Sumesh, Govoni, Marinella, Khalifa, Ahmed
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2017
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5391163/
https://ncbi.nlm.nih.gov/pubmed/28435230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S128665
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller